This expert volume in the Diagnostic Pathology series is an excellent point-of-care resource for practitioners at all levels of experience and training. Physicians should have the knowledge derived from morphological findings to identify the likelihood of a cancer patient having an additional underlying familial syndrome— and to decide if that patient should undergo molecular genetic evaluation. This volume is specifically designed to help pathologists, oncologists, and other physicians who diagnose and treat cancer to recognize syndromes and syndrome- associated neoplasms and advise patients and their families on the possibility of a familial syndrome and their risk of developing other tumors. Diagnostic Pathology: Familial Cancer Syndromes, second edition, is an easy-to-use, one-stop reference for information on hereditary cancer syndromes, including differential diagnosis and management, that offers a templated, highly formatted design; concise, bulleted text; and superior color images throughout.
Since its first publication more than 35 years ago, Enzinger and Weiss’s Soft Tissue Tumors has established itself as the most comprehensive and authoritative reference available on soft tissue pathology. The 7th Edition from Drs. John R. Goldblum, Andrew L. Folpe, and Sharon W. Weiss, continues this tradition with detailed, well-written, logically organized coverage of the full spectrum of these often difficult and challenging tumors. It offers clear guidance to practicing and trainee pathologists on diagnosis of tumors by microscopy, immunohistochemistry, and molecular genetics, as well as a significant amount of clinically significant information of interest to the clinicians who most frequently see these diseases – dermatologists, orthopaedists, and oncologists.
This issue of Surgical Pathology Clinics, Guest Edited by Dr. Justine A. Barletta, will focus on Endocrine Pathology. Topics include, but are not limited to, Pitfalls in Thyroid Cytology, Prognostic Parameters in Differentiated Thyroid Carcinomas, Thyroid Tumors You Don’t Want to Miss, Molecular Alterations in Thyroid Carcinomas, Treatment of Differentiated Thyroid Carcinomas, Treatment of Aggressive Thyroid Carcinomas, A Guide to Pheochromocytomas and Paragangliomas, A Diagnostic Approach to Adrenocortical Tumors, Treatment of Adrenocortical Carcinoma and Pheochromocytomas, Parathyroid Pathology, Neuroendocrine Tumors of the GI Tract and Pancreas, Treatment of GI Neuroendocrine Tumors, and Neuroendocrine Tumors of the Lung.
This issue of Advances in Molecular Pathology will provide a comprehensive review of the most current practices, trends, and developments in the field of Molecular Pathology. Publishing on an annual basis, the volume will be divided into 7 sections: Genetics, Hematopathology, Infectious Disease, Pharmacogenomics, Informatics, Solid tumors, and Identity/HLA. Led by Dr. Gregory Tsongalis of Dartmouth University, a team of experienced pathologists from institutions across the country oversee annual topic and expert author selection.
This issue of Clinics in Laboratory Medicine, guest edited by James E. Kirby, will focus on Advances and Trends in Clinical Microbiology and take a look at the next 20 years. Topics include, but are not limited to, Rapid susceptibility testing methods; Synergy testing; Serology testing re-imagined; Total Laboratory Automation in Clinical Microbiology; MALDI-TOF; Superbugs of the Future, the Antimicrobial Laboratory Resistance Network, Partnerships between Public Health and the clinical microbiology laboratory; Next generation sequencing, from identification to susceptibility prediction; Distributed microbiology testing; Direct from Sample Identification; Biomarkers - predicting viral versus bacterial infection; PK/PD in the era of emerging multidrug-resistance; Training the next generation of clinical microbiologists; and Pictorial illustration of debate, developments, and controversy in clinical microbiology.
This issue of Surgical Pathology Clinics, guest edited by Mina L. Xu, will focus on Hematopathology. Topics include, but are not limited to, EBV associated Lymphoproliferative Disorders; Castleman lymphadenopathy; Early events in lymphoid neoplasms; Changes in cutaneous T-cell lymphoma diagnostic and prognostic considerations; Bone Pathology for Hematopathologists; Acute Leukemias of Ambiguous Lineage; Optimal minimal residual disease testing for AML; Defining boundaries between MDS, MPN and MDS/MPN; Updates in pediatric lymphomas; New entities in gastrointestinal lymphoproliferative disorders; Prognostication in Diffuse Large B-cell Lymphomas; Histiocytic Neoplasms commonly encountered by hematopathologists; and Challenges in the diagnosis of grey zone lymphomas.
This issue of Surgical Pathology Clinics, Guest Edited by Dr. Brooke Howitt, will focus on practical issues and updates around Gynecologic Pathology. This issue is one of four selected each year by the series Consulting Editor, Jason L. Hornick. Topics include, but are not limited to, Non-HPV associated squamous neoplasia of the vulva and vagina; HPV-associated squamous neoplasia of the lower female genital tract; Cervical glandular neoplasia: classification and staging; Preinvasive lesions of the endometrium; Endometrial carcinoma: Grossing, frozen section evaluation, staging, and senitnel lymph node evaluation; High grade endometrial carcinomas: Classification with molecular insights; Uterine mesenchymal tumors: Classification, staging, and updates in molecular testing; Smooth muscle neoplasia of the female genital tract; Germ cell tumors of the female genital tract; Fallopian tube neoplasia and mimics; Low grade serous neoplasia of the female genital tract; Ovarian high grade serous carcinoma: Staging, assessing site of origin and the post-neoadjuvant chemotherapy setting; Ovarian mucinous tumors; Endometrioid and clear cell tumors of the ovary; and Ovarian sex cord stromal tumors.